
Globe Life company profile
$159.37−0.02%Close 17 Nov 2026 · Market value $14.68B
About Globe Life
Globe Life Inc. is an insurance holding company incorporated in Delaware, operating through subsidiaries including Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. Its insurance subsidiaries write nonparticipating ordinary life insurance, including traditional whole life and term life, as well as Medicare Supplement and limited-benefit supplemental health insurance such as accident, cancer, critical illness, and heart coverage. Products are sold to lower middle-income to middle-income Americans through direct-to-consumer channels, exclusive independent agents, and general agency independent agents. The company also operates in Canada, New Zealand, and Bermuda, and engages over 17,000 independently-contracted insurance agents.
A summary of the business section of the company's latest annual report, filed 25 Feb 2026.
Company facts
| Ticker | GL · NYSE |
|---|
| Sector | Insurance |
|---|
| Industry | Life & Health Insurance |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 320335 |
|---|
| Latest annual report | 10-K, filed 25 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Frank M. Svoboda | Co-Chairman & CEO · Director | 479K · < 1% | Option exercise, 12 Jun 2026 |
|---|
| J. Matthew Darden | Co-Chairman & CEO · Director | 313K · < 1% | Option exercise, 31 Jul 2026 |
|---|
| Michael C. Majors | EVP - Chief Strategy Officer | 185K · < 1% | Open-market sale, 23 Oct 2026 |
|---|
| Thomas P. Kalmbach | EVP & CFO | 138K · < 1% | Open-market sale, 30 Jul 2026 |
|---|
| R. Brian Mitchell | EVP, General Counsel and CRO | 120K · < 1% | Open-market sale, 7 Aug 2026 |
|---|
| Robert E. Hensley | EVP & Chief Investment Officer | 70.0K · < 1% | Open-market sale, 22 Sep 2026 |
|---|
| Marilyn A. Alexander | Director | 27.8K · < 1% | Grant or award, 2 Jan 2026 |
|---|
| Cheryl D. Alston | Director | 24.9K · < 1% | Option exercise, 25 Jun 2026 |
|---|
| Linda L. Addison | Director | 20.4K · < 1% | Grant or award, 2 Jan 2026 |
|---|
| Mary E. Thigpen | Director | 18.7K · < 1% | Grant or award, 2 Jan 2026 |
|---|
| James P. Brannen | Director | 10.1K · < 1% | Grant or award, 2 Jan 2026 |
|---|
| David A. Rodriguez | Director | 7.2K · < 1% | Grant or award, 2 Jan 2026 |
|---|
| Mark A. Blinn | Director | 6.5K · < 1% | Open-market sale, 6 Feb 2026 |
|---|
| Alice S. Cho | Director | 5.9K · < 1% | Grant or award, 2 Jan 2026 |
|---|
| Philip M. Jacobs | Director | 2.6K · < 1% | Grant or award, 2 Jan 2026 |
|---|
| Matthew J. Adams | Director | 2.6K · < 1% | Grant or award, 2 Jan 2026 |
|---|
| Sandra L. Phillips | Director | 0 · < 1% | Grant or award, 20 Mar 2026 |
|---|
| Zorn Rebecca E | EVP & Chief Talent Officer | — | Option exercise, 11 Nov 2026 |
|---|
| Skarjune Dolores L | EVP and Chief Admin. Officer | — | Option exercise, 30 Jun 2026 |
|---|
| HENRIE MICHAEL SHANE | SVP & Chief Accounting Officer | — | Open-market sale, 6 May 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
GL in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.